FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4207038818> ?p ?o ?g. }

• W4207038818 abstract "You have accessJournal of UrologyProstate Cancer: Localized: Active Surveillance II (MP62)1 Sep 2021MP62-08 SHARED MEDICAL APPOINTMENTS FOR PROSTATE CANCER ACTIVE SURVEILLANCE FOLLOW-UP VISITS Sigrid Carlsson, Corinne Clauss, Nicole Benfante, Michael Manasia, Tina Sollazzo, Janine Lynch, Jodi Frank, Safia Qaudri, Xin Lin, Andrew Vickers, and Behfar Ehdaie Sigrid CarlssonSigrid Carlsson More articles by this author , Corinne ClaussCorinne Clauss More articles by this author , Nicole BenfanteNicole Benfante More articles by this author , Michael ManasiaMichael Manasia More articles by this author , Tina SollazzoTina Sollazzo More articles by this author , Janine LynchJanine Lynch More articles by this author , Jodi FrankJodi Frank More articles by this author , Safia QaudriSafia Qaudri More articles by this author , Xin LinXin Lin More articles by this author , Andrew VickersAndrew Vickers More articles by this author , and Behfar EhdaieBehfar Ehdaie More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002102.08AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Active surveillance is now the primary approach for men with low risk prostate cancer. To accommodate for the rapidly increasing patient volume and frequent follow-up visits, we carried out a quality improvement project to secure high-quality care and enhance patient experience. We proposed an innovative clinic systems redesign – Shared Medical Appointments (SMAs) – in which multiple patients were seen in a group format at the same time by the health care team. METHODS: The SMAs followed guidelines for conducting SMAs. Patients were invited to SMAs with 6-8 men in each group. Caregivers were welcome to accompany patients as well. The SMAs took place in a conference room. Patients received an information sheet and agreed to a confidentiality and privacy statement. The SMAs comprised: patient education (∼20 minutes), a common clinical management discussion and support from the medical team and peers (∼20-30 minutes), and one-on-one physical examinations in a Urology clinic room (∼20-30 minutes). In addition to meeting patients’ psychosocial and educational needs, the SMA allowed for the medical team to review the patients’ medical charts, answer questions, discuss symptoms and treatment options, change or refill prescriptions, order tests, and review test results. At the end of the SMA, patients filled out a survey, adapted from Rhee et al. RESULTS: We piloted 4 SMAs during July-November 2019 (3x6 and 1x8 patients). Of 64 patients approached, 50 (78%) expressed interest. Running the SMAs was feasible and time-efficient. The group dynamic was open and pleasant. The length of the SMAs varied from 60–86 minutes (average 71 minutes). The majority of patients rated their overall experience with SMA as excellent. Almost all patients responded that they were likely or very likely to attend another SMA in the future. All patients said that they would either definitely or probably recommend this visit type to a friend of family member with prostate cancer. Most patients rated their overall satisfaction with the SMA as extremely high. CONCLUSIONS: Utilizing SMAs for active surveillance follow-up visits was feasible and acceptable. Our findings are very promising and suggest that SMAs can ensure patient satisfaction with care, improve the contact time for each patient (e.g., 60 mins in the SMA instead of 15 mins with their urologist in individual appointments) while at the same time being time- and resource efficient for the healthcare providers (e.g., 8 visits in 60 mins instead of 120 mins) and using the standard billing processes. Source of Funding: NIH/NCI (P30-CA008748 and K22-CA234400) © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e1095-e1095 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Sigrid Carlsson More articles by this author Corinne Clauss More articles by this author Nicole Benfante More articles by this author Michael Manasia More articles by this author Tina Sollazzo More articles by this author Janine Lynch More articles by this author Jodi Frank More articles by this author Safia Qaudri More articles by this author Xin Lin More articles by this author Andrew Vickers More articles by this author Behfar Ehdaie More articles by this author Expand All Advertisement Loading ..." @default.
• W4207038818 created "2022-01-26" @default.
• W4207038818 creator A5011567211 @default.
• W4207038818 creator A5014513524 @default.
• W4207038818 creator A5018231683 @default.
• W4207038818 creator A5018779823 @default.
• W4207038818 creator A5025886998 @default.
• W4207038818 creator A5028756481 @default.
• W4207038818 creator A5051257726 @default.
• W4207038818 creator A5052363775 @default.
• W4207038818 creator A5070966208 @default.
• W4207038818 creator A5075829688 @default.
• W4207038818 creator A5087481089 @default.
• W4207038818 date "2021-09-01" @default.
• W4207038818 modified "2023-09-27" @default.
• W4207038818 title "MP62-08 SHARED MEDICAL APPOINTMENTS FOR PROSTATE CANCER ACTIVE SURVEILLANCE FOLLOW-UP VISITS" @default.
• W4207038818 doi "https://doi.org/10.1097/ju.0000000000002102.08" @default.
• W4207038818 hasPublicationYear "2021" @default.
• W4207038818 type Work @default.
• W4207038818 citedByCount "0" @default.
• W4207038818 crossrefType "journal-article" @default.
• W4207038818 hasAuthorship W4207038818A5011567211 @default.
• W4207038818 hasAuthorship W4207038818A5014513524 @default.
• W4207038818 hasAuthorship W4207038818A5018231683 @default.
• W4207038818 hasAuthorship W4207038818A5018779823 @default.
• W4207038818 hasAuthorship W4207038818A5025886998 @default.
• W4207038818 hasAuthorship W4207038818A5028756481 @default.
• W4207038818 hasAuthorship W4207038818A5051257726 @default.
• W4207038818 hasAuthorship W4207038818A5052363775 @default.
• W4207038818 hasAuthorship W4207038818A5070966208 @default.
• W4207038818 hasAuthorship W4207038818A5075829688 @default.
• W4207038818 hasAuthorship W4207038818A5087481089 @default.
• W4207038818 hasBestOaLocation W42070388181 @default.
• W4207038818 hasConcept C121608353 @default.
• W4207038818 hasConcept C126322002 @default.
• W4207038818 hasConcept C2780192828 @default.
• W4207038818 hasConcept C512399662 @default.
• W4207038818 hasConcept C71924100 @default.
• W4207038818 hasConcept C74909509 @default.
• W4207038818 hasConceptScore W4207038818C121608353 @default.
• W4207038818 hasConceptScore W4207038818C126322002 @default.
• W4207038818 hasConceptScore W4207038818C2780192828 @default.
• W4207038818 hasConceptScore W4207038818C512399662 @default.
• W4207038818 hasConceptScore W4207038818C71924100 @default.
• W4207038818 hasConceptScore W4207038818C74909509 @default.
• W4207038818 hasIssue "Supplement 3" @default.
• W4207038818 hasLocation W42070388181 @default.
• W4207038818 hasOpenAccess W4207038818 @default.
• W4207038818 hasPrimaryLocation W42070388181 @default.
• W4207038818 hasRelatedWork W1996846311 @default.
• W4207038818 hasRelatedWork W2221425694 @default.
• W4207038818 hasRelatedWork W2365364931 @default.
• W4207038818 hasRelatedWork W2418638721 @default.
• W4207038818 hasRelatedWork W2810602217 @default.
• W4207038818 hasRelatedWork W2962601203 @default.
• W4207038818 hasRelatedWork W4243514755 @default.
• W4207038818 hasRelatedWork W4295763953 @default.
• W4207038818 hasRelatedWork W2189427681 @default.
• W4207038818 hasRelatedWork W2530851007 @default.
• W4207038818 hasVolume "206" @default.
• W4207038818 isParatext "false" @default.
• W4207038818 isRetracted "false" @default.
• W4207038818 workType "article" @default.